University of Medicine and Pharmacy Iuliu Hatieganu, Drug Information Research Center, Pasteur 6, Cluj-Napoca, Romania.
Eur J Intern Med. 2010 Oct;21(5):453-7. doi: 10.1016/j.ejim.2010.05.014. Epub 2010 Jun 23.
It is generally recognized that adverse drug reactions (ADRs) represent a major concern of health systems in terms of early recognition, proper management and prevention. The aims of this study were to identify the most frequent ADRs recognized by the attending physicians, study their nature and target these ADRs in order to take future preventive measures.
A prospective study was conducted over a 12-month period in an internal medicine department using stimulated spontaneous reporting for identifying ADRs. All ADRs reported by physicians were followed up to the patient's discharge and evaluated by an independent group of pharmacologists. Causality, severity and preventability were assessed.
Of the 1854 admissions, 112 ADRs in 94 patients (5.07%) were validated from the total of 118 ADRs reported. The overall incidence of serious ADRs in the hospitalized patients was 4.7%. According to the MedDRA classification, the most frequent ADRs affected the gastrointestinal system, followed by metabolic and vascular systems. The drugs most frequently involved were cardiovascular agents, anticoagulants and NSAIDs. Drug interactions were responsible for 25.9% of ADRs. According to the selected preventability scale, 40.18% ADRs were classified as 'potentially preventable' and 9.82% 'definitely preventable'. Most of the ADRs were 'type A' reactions and as such could have been avoided simply by adjusting the doses or by avoiding drug interactions.
Serious ADRs in hospitalized patients are common and often preventable. Preventing strategies should target drug prescription. Adequate training regarding pharmacology and optimization of drug therapy might help reduce ADRs' morbidity and mortality.
人们普遍认为,药物不良反应(ADR)是医疗体系早期识别、妥善管理和预防的主要关注点。本研究旨在识别主治医生识别出的最常见 ADR,研究其性质,并针对这些 ADR 采取预防措施。
在 12 个月的时间里,我们在内科部门进行了一项前瞻性研究,通过自发报告识别 ADR。医生报告的所有 ADR 都进行了随访,直至患者出院,并由一组独立的药理学家进行评估。评估的指标包括关联性、严重程度和可预防程度。
在 1854 例住院患者中,从报告的 118 例 ADR 中验证了 94 例患者的 112 例 ADR(5.07%)。住院患者严重 ADR 的总发生率为 4.7%。根据 MedDRA 分类,最常见的 ADR 影响胃肠道系统,其次是代谢和血管系统。最常涉及的药物是心血管药物、抗凝剂和 NSAIDs。药物相互作用导致了 25.9%的 ADR。根据所选的可预防程度量表,40.18%的 ADR 被归类为“可能可预防”,9.82%为“绝对可预防”。大多数 ADR 为“A 型”反应,因此通过调整剂量或避免药物相互作用即可避免。
住院患者中严重 ADR 很常见,且往往是可预防的。预防策略应针对药物处方。充分的药理学培训和优化药物治疗可能有助于降低 ADR 的发病率和死亡率。